Key Takeaways:
- IDEX reported Q2 adjusted EPS of $2.32, beating the $2.10 consensus by 10.5%
- Revenue rose 6.4% to $920.6M, driven by 14% growth in Health & Science Technologies
- The company raised its full-year adjusted EPS guidance to $8.70-$8.85
戻る
IDEX beats Q2 estimates, raises full-year outlook on record orders
IDEX Corp. reported Q2 adjusted earnings of $2.32 a share, topping estimates by 10.5%, as record orders topped $1 billion.
"Strong execution across our businesses drove record orders and margin expansion," IDEX said in its earnings statement, citing growth in AI-linked data center power and semiconductor end markets.
Revenue of $920.6 million surpassed the consensus estimate of $902.4 million and rose 6.4% from $865.4 million a year earlier. Organic sales increased 5%, while acquisitions contributed 1%. The Health & Science Technologies segment led with $415 million in sales, up 14%, driven by demand from AI data center power, semiconductor, and space and defense markets. Fluid & Metering Technologies posted $317.1 million, up 2%, and Fire & Safety/Diversified Products slipped 1% to $189.9 million.
Adjusted gross margin expanded 110 basis points to 46.4% on net productivity improvements, volume leverage and positive price-cost dynamics, partially offset by unfavorable mix. Adjusted EBITDA rose 8.9% to $258.3 million, with margin improving 70 basis points to 28.1%. Operating income increased 6.4% to $199.9 million, with operating margin holding at 21.7%.
The company generated $303.7 million in cash from operations in the first six months, up 13.6% from a year earlier. Free cash flow reached $263 million, up 10.4%. IDEX held $621.3 million in cash and equivalents at quarter-end, compared with $580 million at the end of 2025. Long-term borrowings stood at $1.86 billion. The company paid $106.7 million in dividends during the first half, up 0.8% year over year.
IDEX raised its full-year 2026 organic sales growth forecast to 5%-6% from 3%-4% and lifted adjusted EPS guidance to $8.70-$8.85 from $8.35-$8.55. For the third quarter, the company expects organic sales growth of 5%-7% and adjusted EPS of $2.20-$2.25. The updated outlook reflects confidence in sustained demand across key end markets.
Shares of IDEX have gained 26.3% year to date, outpacing the S&P 500's 8.5% advance. The stock carries a Zacks Rank #3 (Hold). Among industrial peers, Graco Inc. also reported a beat last quarter, with adjusted EPS rising 17% to 91 cents, while Generac Holdings posted a 76% earnings surge to $2.91 a share.
The guidance raise indicates management expects demand from AI-linked end markets and semiconductor segments to sustain momentum. Investors will watch the Q3 earnings call for further updates on segment margin trends and order book conversion.
This article is for informational purposes only and does not constitute investment advice.
